1969
DOI: 10.7326/0003-4819-71-4-779
|View full text |Cite
|
Sign up to set email alerts
|

Prolonged Survival in Lymphangitic Carcinomatosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1975
1975
2012
2012

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…1 had been made premortem, and the patient treated with castration or estrogen therapy. A case of adenocarcinoma of the prostate with lymphangitic carcinomatosis and dyspnea was successfully treated with castration by Schwartz et al 29 Emirgil et a1.I2 reported a short-lived response to prednisone treatment in a patient with lymphangitic carcinomatosis from a carcinoma of the breast. Bagshawe and Brooks5 treated two patients with choriocarcinoma tumor emboli using methotrexate and 6-mercap topurine, with excellent clinical improvement.…”
Section: Vol 36mentioning
confidence: 99%
“…1 had been made premortem, and the patient treated with castration or estrogen therapy. A case of adenocarcinoma of the prostate with lymphangitic carcinomatosis and dyspnea was successfully treated with castration by Schwartz et al 29 Emirgil et a1.I2 reported a short-lived response to prednisone treatment in a patient with lymphangitic carcinomatosis from a carcinoma of the breast. Bagshawe and Brooks5 treated two patients with choriocarcinoma tumor emboli using methotrexate and 6-mercap topurine, with excellent clinical improvement.…”
Section: Vol 36mentioning
confidence: 99%
“…Pulmonary lymphangitic spread of prostate cancer that is confirmed pathologically via lung biopsy is rarely reported. To our knowledge, only 7 cases described biopsy-proven lymphangitic metastasis from prostate cancer, but surprisingly none occurred in the castration-resistant setting (Table 1) [28]. We describe a rare case of biopsy-proven pulmonary lymphangitic metastasis in the castration-resistant setting.…”
Section: Discussionmentioning
confidence: 87%